about
Targeting Selectins and Their Ligands in CancerImaging circulating tumor cells in freely moving awake small animals using a miniaturized intravital microscopeDeoxygenated Disaccharide Analogs as Specific Inhibitors of 1-4-Galactosyltransferase 1 and Selectin-mediated Tumor MetastasisDC - SIGNR by influencing the lncRNA HNRNPKP2 upregulates the expression of CXCR4 in gastric cancer liver metastasis.Modeling tumor microenvironments in vitro.Systemic inflammation promotes lung metastasis via E-selectin upregulation in mouse breast cancer model.CCR4 is a determinant of melanoma brain metastasisSweetening the pot: adding glycosylation to the biomarker discovery equationDrug resistance in cancer: an overview.Phenotypic switch in blood: effects of pro-inflammatory cytokines on breast cancer cell aggregation and adhesionTargeting liposomes loaded with melphalan prodrug to tumour vasculature via the Sialyl Lewis X selectin ligand.Leukocyte transmigration across endothelial and extracellular matrix protein barriers in liver ischemia/reperfusion injury.The emerging importance of α-L-fucose in human breast cancer: a review.A lectin affinity workflow targeting glycosite-specific, cancer-related carbohydrate structures in trypsin-digested human plasma.Cancer cell adhesion and metastasis: selectins, integrins, and the inhibitory potential of heparinsLectin chromatography/mass spectrometry discovery workflow identifies putative biomarkers of aggressive breast cancers.Pilot study on "pericytic mimicry" and potential embryonic/stem cell properties of angiotropic melanoma cells interacting with the abluminal vascular surface.Variation in Carbohydrates between Cancer and Normal Cell Membranes Revealed by Super-Resolution Fluorescence Imaging.Cancer and Thrombosis: The Platelet Perspective.The engagement of selectins and their ligands in colorectal cancer liver metastases.Altered tumor-cell glycosylation promotes metastasis.Bone metastasis risk factors in breast cancer.Selectin Ligands Sialyl-Lewis a and Sialyl-Lewis x in Gastrointestinal Cancers.Malignant melanoma as a target malignancy for the study of the anti-metastatic properties of the heparins.Biomarkers of endothelial dysfunction: can they help us deciphering systemic inflammation and sepsis?Endothelium and regulatory inflammatory mechanisms during organ rejection.Cancer development, progression, and therapy: an epigenetic overview.Metastasis review: from bench to bedside.2-Oxabutane as a substitute for internal monomer units of oligosaccharides to create lectin ligands.lnflammation-induced epigenetic switches in cancer.MOLECULAR PATHWAYS: TARGETING THE MICROENVIRONMENT OF LIVER METASTASES.Loss of the endothelial glycocalyx is associated with increased E-selectin mediated adhesion of lung tumour cells to the brain microvascular endothelium.Zooming in on selectins in cancer.The role of vitamin D in hepatic metastases from colorectal cancer.The p38 pathway, a major pleiotropic cascade that transduces stress and metastatic signals in endothelial cells.Inhibition of P-Selectin and PSGL-1 Using Humanized Monoclonal Antibodies Increases the Sensitivity of Multiple Myeloma Cells to Bortezomib.Could pericytic mimicry represent another type of melanoma cell plasticity with embryonic properties?Cell adhesion molecules in metastatic neuroblastoma models.Electrophoretic cytometry of adherent cells.Selectins in cancer immunity.
P2860
Q26752384-97AAE5C6-5309-46E8-982B-58CD8029D4CCQ27329640-35DDB672-B64D-4EC0-8876-EC0692890F80Q27653257-F7238938-7D76-4C8A-BE96-8C32B881A652Q33560349-FC9A4FC4-6C72-4EAD-B9D5-7CFC41B42526Q33622546-93DE5223-7A33-47AA-96C5-A66F0DB01361Q33727882-7C407F02-0737-4E7E-AD2D-91052F5B32E0Q33761639-ED4D0D58-530C-44C1-A689-06EE0171E1A9Q33768460-7CE720F8-B613-4E23-B09E-CFE631CDDBC0Q34437369-688E23C3-06A5-4326-B5A7-1C260AD396DAQ34571490-D6822CD3-C5D1-469B-B29D-4269D04D8CB0Q35061731-86591814-EED2-462A-914E-A68396F9E66EQ35167030-9F95ECC7-FA33-4769-9203-20A277EB2CF0Q35172546-CD630B57-8636-42DC-B34A-D62854F18024Q35499086-2F042872-2FB1-4C14-A29D-C2F923EF0200Q35810537-509491F3-CFA6-41F4-A4EF-CC5FFF171828Q36058024-E2092A9D-B77E-4489-B205-1B1AF70C323AQ36695074-78D30877-E620-4401-92B6-B0AF2114AA1EQ37505096-C436ABFD-B093-47C9-8EAB-9287EC47A6D9Q37558436-E1705D30-D788-448F-8D2F-1D77392843D6Q37559776-8BA95053-ED67-49F9-900E-DA81698AA53EQ37581540-A608099F-7230-45A2-81D6-2668246CBF36Q37629662-1CF61CC9-36AC-4684-B2F2-79D5038F3A65Q37728199-56098ABC-8C28-4C99-91A0-104671FBD3BFQ37799290-04769987-F9C8-475E-87AF-8D1D4A1AFD56Q37894728-DAE01C95-4ED7-43D0-8B1B-4D703490A978Q38103486-9A059FD4-E05C-41F9-AE93-90C76B10BA9BQ38154977-6E3529ED-A2E4-4D97-B7DF-A4B434AC847FQ38237985-444A8770-0F44-4FF0-99AF-4D9CEE028CF3Q38332627-4E2FD0C5-1215-4CD4-882F-87FFA6A1427FQ38591056-1C69CE27-8546-44A4-9DA6-B7C0CF77B036Q38671001-A6513DAD-D367-449F-B205-5D94F6877DDAQ38832390-7F28CB98-968C-420D-85C5-10EF0F9D7763Q38881362-843B403A-B116-4767-80C1-872863C83693Q40085423-773C0B62-2021-4795-BE4D-3AD8BCFAF069Q41547499-F906947D-53D8-4DD7-B2EE-C5365BA51B42Q42598619-7E7855C4-B67E-4AF7-9AC0-93C02755807CQ45117869-D75B10F0-781C-4BEC-9BBE-CD83841DB7A4Q45862626-2DA5C58A-F64E-4BBD-A445-7CF04539C2FFQ46622230-45AD09B7-84B6-4111-A01E-3B55C4445377Q49617012-C78310F2-ECC3-4A09-B0AD-7140062C8C2C
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The selectin-selectin ligand axis in tumor progression.
@en
The selectin-selectin ligand axis in tumor progression.
@nl
type
label
The selectin-selectin ligand axis in tumor progression.
@en
The selectin-selectin ligand axis in tumor progression.
@nl
prefLabel
The selectin-selectin ligand axis in tumor progression.
@en
The selectin-selectin ligand axis in tumor progression.
@nl
P2860
P1476
The selectin-selectin ligand axis in tumor progression.
@en
P2093
Isaac P Witz
P2860
P2888
P356
10.1007/S10555-007-9101-Z
P577
2008-03-01T00:00:00Z